Paul Harnish, MD
Cardiovascular Disease · Columbus, OHNPI 1821416231
Payments from drug & device makers
What this record shows
This record is dominated by grants: $35,661 of the $48,999 with a category attached, or 72.8%. Medtronic accounts for 60.6% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $24,552 and has fallen 88.1% since, to $2,917 in 2025. Among cardiovascular disease clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 115 payments — averaging $426.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$30K
- Boston Scientific$10K
- Abbott$6K
- Biotronik Inc.$2K
- Biosense Webster, Inc.$255
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$217
- plus $436 from 5 others
What the payments were for
- Grants$35,66173%
- Travel & lodging$7,26015%
- Food & beverage$5,79912%
- Education$2791%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 29 | $29,681 |
| Boston Scientific | 17 | $9,811 |
| Abbott | 42 | $6,450 |
| Biotronik Inc. | 16 | $2,149 |
| Biosense Webster, Inc. | 2 | $255 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $217 |
| Mallinckrodt Hospital Products Inc. | 1 | $142 |
| Johnson & Johnson | 1 | $125 |
| Astellas Pharma US Inc | 1 | $100 |
| Novartis | 3 | $47 |
| Abiomed | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM MRI S-ICD$5,000
- EMBLEM$3,750
- ACCENT$2,975
- AVEIR$1,463
- Micra$903
- EVERA MRI XT DR SURESCAN$845
- ENSITE PRECISION$466
- ENSITE$338
- AFFERA MAPPING SYSTEM$320
- WATCHMAN FLX$288
- Carto 3$255
- WATCHMAN Access System$177
- EnSite Precision Cardiac Mapping System$154
- Rhythmia Mapping System$150
- Zero Gravity$147
- ACTHAR$142
- XARELTO$125
- Acticor 7 VR-T DX$125
- LifeVest$121
- Soundstar$109
How this compares
$48,999 in reported general payments places this provider in the 90th percentile of 827 cardiovascular disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $28,886 |
| Metoprolol Succinate | 29 | $623 |
| Flecainide Acetate | 12 | $520 |
| Amiodarone Hcl | 11 | $241 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Columbus
- Jayanta MukherjeeColumbus$227K
- Steven DeanColumbus$153K
- Manmohan KatapadiColumbus$124K
- David RichardsColumbus$55K
- Akira WadaColumbus$49K
- Guilherme AttizzaniCleveland$1.3M
- Gregory LamCircleville$428K
- Emil HayekHudson$379K
- Abraham LincoffCleveland$369K
- Oussama WazniCleveland$367K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.